男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

腫瘤壞死因子配體超家族成員13(TNFSF13)多克隆抗體

Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 13 (TNFSF13)

CD256; APRIL; TALL2; TRDL1; ZTNF2; A Proliferation Inducing Ligand; TNF And APOL Related Leukocyte Expressed Ligand 2; TNF-Related Death Ligand 1

  • 腫瘤壞死因子配體超家族成員13(TNFSF13)多克隆抗體產品包裝(模擬)
  • 腫瘤壞死因子配體超家族成員13(TNFSF13)多克隆抗體產品包裝(模擬)
  • 腫瘤壞死因子配體超家族成員13(TNFSF13)多克隆抗體DAB staining on IHC-P; Samples: Human Cardiac Muscle Tissue; Primary Ab: 20μg/ml Rabbit Anti-Simian TNFSF13 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • 腫瘤壞死因子配體超家族成員13(TNFSF13)多克隆抗體DAB staining on IHC-P;
    Samples: Human Kidney Tissue;
    Primary Ab: 20μg/ml Rabbit Anti-Simian TNFSF13 Antibody
    Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 腫瘤壞死因子配體超家族成員13(TNFSF13)多克隆抗體DAB staining on IHC-P;
    Samples: Human Spleen Tissue;
    Primary Ab: 20μg/ml Rabbit Anti-Simian TNFSF13 Antibody
    Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • PAB750Si01.jpgWB圖
  • Certificate通過ISO 9001、ISO 13485質量體系認證

特異性

該抗體是針對TNFSF13的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別TNFSF13。

用法

免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學：5-20μg/mL;1:25-100
免疫細胞化學：5-20μg/mL;1:25-100
最佳稀釋倍數最終由用戶決定。

儲存

經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。

贈品

相關產品

編號適用物種：Rhesus monkey (Simian，恒河猴)應用(僅供研究使用，不用于臨床診斷！)
RPB750Si01腫瘤壞死因子配體超家族成員13(TNFSF13)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAB750Si01腫瘤壞死因子配體超家族成員13(TNFSF13)多克隆抗體WB; IHC; ICC; IP.

參考文獻

雜志參考文獻
Journal of Critical Care Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients[PubMed: 23337484]
HaematologicaArrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells[Pubmed: 30819903]
GeneA Significant Decrease of BAFF, APRIL, and BAFF Receptors Following Mesenchymal Stem Cell Transplantation in Patients with Refractory Rheumatoid Arthritis[Pubmed: 31935514]